Screener
LeMaitre Vascular LMAT EBITDA
EBITDA at other companies
Other financials
Where this comes from
Calculated from LeMaitre Vascular’s reported figures.
The source filing: LeMaitre Vascular’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 6:30 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-333762
FAQ
- What is LeMaitre Vascular's EBITDA?
- LeMaitre Vascular (LMAT) reported EBITDA of $23.06M in Q2 2026.
- How has LeMaitre Vascular's EBITDA changed year-over-year?
- LeMaitre Vascular's EBITDA increased by 22.7% year-over-year, from $18.79M to $23.06M.
- What is the long-term trend for LeMaitre Vascular's EBITDA?
- Over 3 years (2022 to 2025), LeMaitre Vascular's EBITDA has grown at a 29.3% compound annual growth rate (CAGR), from $36.26M to $78.33M.
- What does EBITDA mean?
- Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.
Ask your AI about LeMaitre Vascular's ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude